DOI:
10.1055/s-00000012
Endoscopy
LinksClose Window
References
Andre T, de Gramont A, Vernerey D. et al.
Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study.
J Clin Oncol 2015;
33: 4176-4187
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.